Chiron Gets Go-Ahead to Resume Production of Flu Vaccines; Henry Schein Shares Rise 4.4%

Long Island Business News › March 04, 2005

Linked as:

Summary

Just a day after Henry Schein pointed to concerns about Chiron's continuing inability to supply it with flu vaccine, the firm got a healthy shot of good news.

On Wednesday, Chiron said that British regulators have given it the go-ahead to resume production of flu vaccines, ending a five- month suspension.

See the full content of this document

Extract

Chiron Gets Go-Ahead to Resume Production of Flu Vaccines; Henry Schein Shares Rise 4.4%

While Chiron...

See the full content of this document